Remission in Rheumatoid Arthritis: Working Toward Incorporation of the Patient Perspective at OMERACT 12
- PMID: 25684772
- DOI: 10.3899/jrheum.141113
Remission in Rheumatoid Arthritis: Working Toward Incorporation of the Patient Perspective at OMERACT 12
Abstract
Objective: The treatment of rheumatoid arthritis (RA) should target patient-relevant outcomes, making patient perspective on remission essential. In 2010, patients, physicians, health professionals, and researchers at the Outcome Measures in Rheumatology (OMERACT) conference developed an ambitious research agenda to study the concept of remission. Qualitative research has since helped us understand the concept of remission from the patient perspective.
Methods: During OMERACT 12, the OMERACT working group on patient perspective on remission in RA elaborated on data generated to date and discussed the methodological challenges ahead. Challenges included (1) selection of domains, (2) choice of a patient remission definition or a single domain to add to the current remission definition, and (3) the importance of pain in defining remission from a patient perspective.
Results: Focus in the coming years will be on increasing our understanding by identifying the most important domains from the patient perspective regarding remission and investigating how these domains can be measured. Investigation into the Rheumatoid Arthritis Impact of Disease questionnaire, disease flare, as well as the concordance of domains from our ongoing remission survey is appropriate. More data and further discussions are needed to decide on the next steps.
Conclusion: Progress summarized over 4 years highlights the main methodological challenges discussed within the working group on patient perspective on remission in RA during OMERACT 12.
Keywords: OMERACT; PATIENT PERSPECTIVE; PATIENT-REPORTED OUTCOME; REMISSION; RHEUMATOID ARTHRITIS.
Similar articles
-
Establishing a core domain set to measure rheumatoid arthritis flares: report of the OMERACT 11 RA flare Workshop.J Rheumatol. 2014 Apr;41(4):799-809. doi: 10.3899/jrheum.131252. Epub 2014 Mar 1. J Rheumatol. 2014. PMID: 24584927 Free PMC article. Review.
-
Validating Rheumatoid Arthritis Remission Using the Patients' Perspective: Results from a Special Interest Group at OMERACT 2016.J Rheumatol. 2017 Dec;44(12):1889-1893. doi: 10.3899/jrheum.161111. Epub 2017 Aug 1. J Rheumatol. 2017. PMID: 28765250
-
Patient perspective on remission in rheumatoid arthritis.J Rheumatol. 2011 Aug;38(8):1735-8. doi: 10.3899/jrheum.110394. J Rheumatol. 2011. PMID: 21807794
-
Developing a standardized definition for disease "flare" in rheumatoid arthritis (OMERACT 9 Special Interest Group).J Rheumatol. 2009 Oct;36(10):2335-41. doi: 10.3899/jrheum.090369. Epub 2009 Aug 14. J Rheumatol. 2009. PMID: 19684147
-
More than Just Minutes of Stiffness in the Morning: Report from the OMERACT Rheumatoid Arthritis Flare Group Stiffness Breakout Sessions.J Rheumatol. 2015 Nov;42(11):2182-4. doi: 10.3899/jrheum.141172. Epub 2015 Mar 1. J Rheumatol. 2015. PMID: 25729035 Free PMC article. Review.
Cited by
-
Summarizing current refractory disease definitions in rheumatoid arthritis and polyarticular juvenile idiopathic arthritis: systematic review.Rheumatology (Oxford). 2021 Aug 2;60(8):3540-3552. doi: 10.1093/rheumatology/keab237. Rheumatology (Oxford). 2021. PMID: 33710321 Free PMC article.
-
Prevalence and Factors Associated With Patient-Clinician Discordance Among Patients With Rheumatoid Arthritis Initiating Advanced Therapy.ACR Open Rheumatol. 2024 May;6(5):253-264. doi: 10.1002/acr2.11587. Epub 2024 Mar 1. ACR Open Rheumatol. 2024. PMID: 38429905 Free PMC article.
-
Impact of tapering targeted therapies (bDMARDs or JAKis) on the risk of serious infections and adverse events of special interest in patients with rheumatoid arthritis or spondyloarthritis: a systematic analysis of the literature and meta-analysis.Arthritis Res Ther. 2020 Apr 29;22(1):97. doi: 10.1186/s13075-020-02188-x. Arthritis Res Ther. 2020. PMID: 32349791 Free PMC article.
-
Tofacitinib versus methotrexate in rheumatoid arthritis: patient-reported outcomes from the randomised phase III ORAL Start trial.RMD Open. 2016 Sep 28;2(2):e000308. doi: 10.1136/rmdopen-2016-000308. eCollection 2016. RMD Open. 2016. PMID: 27752357 Free PMC article.
-
Incorporating the patient's perspective in outcomes research.Curr Opin Rheumatol. 2017 Mar;29(2):144-149. doi: 10.1097/BOR.0000000000000372. Curr Opin Rheumatol. 2017. PMID: 28072590 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical